Director at Nutex Health (NUTX) receives grant of 823 RSUs vesting 2027

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Reed Michael Lee reported acquisition or exercise transactions in this Form 4 filing.

Nutex Health Inc. director Michael Lee received a grant of 823 Restricted Stock Units (RSUs) as equity compensation. Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on April 23, 2027, with pro-rata vesting if he leaves the company without cause during the vesting period. Following this award, Lee holds a total of 1,426 RSUs directly. This filing reflects a compensation-related stock unit grant, not an open-market share purchase or sale.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Reed Michael Lee

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (RSUs)	823	$0.00	--

Holdings After Transaction: Restricted Stock Units (RSUs) — 1,426 shares (Direct, null)

Footnotes (1)

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Key Figures

RSUs granted: 823 RSUs Transaction price per RSU: $0.0000 per unit Total RSUs after grant: 1,426 RSUs +1 more

4 metrics

RSUs granted 823 RSUs Grant to director Michael Lee on April 23, 2026

Transaction price per RSU $0.0000 per unit Equity compensation grant, non-cash transaction

Total RSUs after grant 1,426 RSUs Director Michael Lee’s holdings following reported transaction

RSU vesting date April 23, 2027 100% vesting date for 823 granted RSUs

Key Terms

Restricted Stock Units (RSUs), vesting, pro-rata basis, contingence right to receive one share

4 terms

Restricted Stock Units (RSUs) financial

"The Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

vesting financial

"823 RSUs, which vest 100% on April 23, 2027."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

pro-rata basis financial

"the RSUs shall vest on a pro-rata basis for the actual time in service"

Allocation or distribution that gives each participant a share proportional to their existing ownership, stake or entitlement — like slicing a pie so everyone gets a piece matching how big their original slice was. For investors this matters because it determines how much of new shares, dividends, fees or obligations they receive, helps preserve or change ownership percentages, and directly affects dilution and voting power.

Form 4 Insider Transactions: What Each Field Means →

04/24/2026 - 02:35 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reed Michael Lee

(Last)

(First)

(Middle)

1776 YORKTOWN STREET SUITE 700

C/O NUTEX HEALTH INC.

(Street)

HOUSTON

TEXAS

77056

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSUs)	$0⁽¹⁾	04/23/2026		A		823		04/23/2027⁽²⁾	04/23/2027⁽²⁾	Common Stock	823	$0⁽¹⁾	1,426	D

Explanation of Responses:

1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

2. On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

	/s/ Michael Reed	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Nutex Health (NUTX) director Michael Lee report on this Form 4?

Michael Lee reported receiving 823 Restricted Stock Units (RSUs) from Nutex Health as equity compensation. These units are a right to receive common shares in the future, rather than an immediate stock purchase or sale in the open market.

How many Nutex Health (NUTX) RSUs does Michael Lee hold after this grant?

After this grant, Michael Lee holds a total of 1,426 Restricted Stock Units in Nutex Health. This total reflects his existing RSU balance plus the newly granted 823 units reported in this Form 4 insider transaction filing.

When do Michael Lee’s new Nutex Health (NUTX) RSUs vest?

The 823 Nutex Health RSUs granted to Michael Lee vest 100% on April 23, 2027. Until that vesting date, they remain unvested awards that convert into common stock only when the vesting conditions are fully satisfied.

What happens to Michael Lee’s Nutex Health (NUTX) RSUs if he leaves before vesting?

If Michael Lee leaves Nutex Health without cause before April 23, 2027, his 823 RSUs will vest on a pro-rata basis. The vested amount will be based on the actual time he spent in service during the vesting period.

Do Michael Lee’s Nutex Health (NUTX) RSUs involve any cash transaction?

The RSU grant to Michael Lee carries a transaction price of $0.0000 per unit, indicating no cash was paid. RSUs are compensation awards that convert into common shares upon vesting instead of being bought in a traditional market transaction.

How many Nutex Health (NUTX) shares can Michael Lee receive from this RSU grant?

Each RSU represents the right to receive one share of Nutex Health common stock. Therefore, the 823 RSUs granted to Michael Lee can convert into 823 common shares if the vesting conditions, including service through the vesting date, are met.